Similar articles

• Routine aspirin or nonsteroidal anti-inflammatory drugs for the primary prevention of colorectal cancer: U.S. Preventive Services Task Force recommendation statement.

  U.S. Preventive Services Task Force. U.S. Preventive Services Task Force. Ann Intern Med. 2007 Mar 6;146(5):361-4. Ann Intern Med. 2007. PMID: 17339621
• Summaries for patients. Aspirin or nonsteroidal anti-inflammatory drugs for the prevention of colorectal cancer: U.S. Preventive Services Task Force recommendations.

  [No authors listed] [No authors listed] Ann Intern Med. 2007 Mar 6;146(5):I35. doi: 10.7326/0003-4819-146-5-200703060-00003. Ann Intern Med. 2007. PMID: 17339615 No abstract available.
• Aspirin and other nonsteroidal anti-inflammatory agents in the prevention of colorectal cancer.

  Sandler RS. Sandler RS. Important Adv Oncol. 1996:123-37. Important Adv Oncol. 1996. PMID: 8791132 Review.
• Clinical inquiries. Is aspirin effective for primary prevention of colon cancer?

  Rufner KL, Park MK, Tweed EM. Rufner KL, et al. J Fam Pract. 2010 Jul;59(7):E410c-d. J Fam Pract. 2010. PMID: 20625563 Review. No abstract available.
• A randomized trial of aspirin to prevent colorectal adenomas.

  Baron JA, Cole BF, Sandler RS, Haile RW, Ahnen D, Bresalier R, McKeown-Eyssen G, Summers RW, Rothstein R, Burke CA, Snover DC, Church TR, Allen JI, Beach M, Beck GJ, Bond JH, Byers T, Greenberg ER, Mandel JS, Marcon N, Mott LA, Pearson L, Saibil F, van Stolk RU. Baron JA, et al. N Engl J Med. 2003 Mar 6;348(10):891-9. doi: 10.1056/NEJMoa021735. N Engl J Med. 2003. PMID: 12621133 Clinical Trial.